SRx Health Solutions Regains Compliance with NYSE

SRx Health Solutions (NYSE American: SRXH) announced that the New York Stock Exchange accepted its plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.

Rhea-AI Summary

SRx Health Solutions (NYSE American: SRXH) announced that the New York Stock Exchange accepted its plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. The Company's listing will continue under an extension with a targeted completion date of July 14, 2026 (the Plan Period). NYSE had notified the Company on October 14, 2025 that it fell below the requirement to maintain $4 million or more in stockholders' equity after reporting losses in three of four most recent fiscal years. The Company will provide quarterly updates to NYSE American during the Plan Period on progress toward the plan's goals.

Positive

• NYSE accepted the Company’s compliance plan to retain listing
• Listing continued under an extension through July 14, 2026
• Company committed to provide quarterly progress updates to NYSE American

Negative

• Company notified Oct 14, 2025 of stockholders' equity below $4 million
• Reported losses in three of the four most recent fiscal years

Argus Jan 8 session

-0.95% close to close Open Argus

Details

News Market Reaction – SRXH

On Jan 8, the day this news came out, SRXH closed 0.95% below the previous close.

Data tracked by StockTitan Argus for the Jan 8 session.

Market Context

This announcement confirms NYSE American has accepted SRXH’s plan to regain compliance with equity-b...

Analysis

This announcement confirms NYSE American has accepted SRXH’s plan to regain compliance with equity-based continued listing standards, extending its Plan Period to July 14, 2026 with required quarterly updates. The stock remained weak near its $0.1874 52-week low and well below the $2.02 high, reflecting prior pressures tied to complex financings and strategic shifts. Key issues to monitor include progress toward equity thresholds, execution of the broader EMJX-focused strategy, and the impact of any additional capital-raising activity.

Key Figures

Equity requirement: $4,000,000 Plan completion date: July 14, 2026 Current price: $0.201 +5 more

Equity requirement

$4,000,000

NYSE American continued listing stockholders’ equity threshold in Section 1003(a)(i)

Plan completion date

July 14, 2026

Targeted end of NYSE American compliance Plan Period

Current price

$0.201

Pre-news trading level vs 52-week range

52-week high

$2.02

SRXH 52-week high before compliance news

52-week low

$0.1874

SRXH 52-week low before compliance news

Market cap

$14,064,143

Equity value at latest pre-news close

Volume today

11,436,511 shares

Compared with 20-day average volume of 37,294,563 shares

Plan updates

Quarterly

Company to provide quarterly progress reports to NYSE American

Historical Context

5 past events · Latest: Dec 30

5 events

1. Dec 30

   Crypto deployment

   24h Move

   -3.2%

   Deployed $10 million into Bitcoin, Ethereum and other digital assets.

2. Dec 23

   Risk framework update

   24h Move

   -26.2%

   Expanded EMJX risk-intelligence framework using prediction-market probability data.

3. Dec 19

   AI integration

   24h Move

   -6.9%

   Integrated OpenAI LLMs into Gen2 Digital Asset Treasury and QAM Engine.

4. Dec 16

   Acquisition agreement

   24h Move

   +23.8%

   Entered definitive agreement to acquire EMJX and related AI treasury platform.

5. Nov 10

   Board appointment

   24h Move

   -7.5%

   Appointed Sammy Dorf to Board, highlighting capital markets and crypto experience.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

continued listing standards, stockholders’ equity

2 terms

continued listing standards regulatory

"regain compliance with the continued listing standards in Sections 1003(a)(i) and (ii)"

Ongoing rules a stock exchange requires a listed company to meet to keep its shares trading publicly, such as minimum share price, market value, timely financial reports, and governance practices. Think of it as a membership checklist for a club: falling short can lead to warnings or removal from the exchange, which can sharply reduce liquidity, investor confidence, and a stock’s value. Investors watch these standards to gauge regulatory risk and the stability of their holdings.

stockholders’ equity financial

"fallen below the NYSE’s continued listing standard requiring a listed company to have stockholders’ equity of $4 million or more"

Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH PALM BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that the New York Stock Exchange (“NYSE”) has accepted the Company’s plan to regain compliance with the continued listing standards in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.

As previously disclosed, NYSE notified the Company on October 14, 2025 that the Company had fallen below the NYSE’s continued listing standard requiring a listed company to have stockholders’ equity of $4 million or more if the listed company has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. With the NYSE’s acceptance of the Company’s plan to regain compliance, the Company’s listing is being continued pursuant to an extension with a targeted completion date of July 14, 2026 (the “Plan Period”). The Company will provide quarterly updates to the NYSE American during the Plan Period on its progress with the goals and initiatives outlined in the plan.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,” “target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

Company Contact
SRx Health Solutions, Inc.
Kent Cunningham, Chief Executive Officer

Investor Relations Contact
KCSA Strategic Communications
Valter Pinto, Managing Director
212-896-1254
valter@kcsa.com

Media Contact
KCSA Strategic Communications
Kristin Cwalinski, Senior Vice President
EMJX@KCSA.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SRXH announce about its NYSE American listing on January 8, 2026?

The company said NYSE accepted its plan to regain compliance and extended the listing through July 14, 2026.

Why was SRXH previously noncompliant with NYSE American listing standards?

NYSE notified SRXH on October 14, 2025 that stockholders' equity fell below the $4 million threshold after losses in three of four recent fiscal years.

What is the targeted deadline for SRXH to regain compliance with NYSE American?

The Plan Period targets completion by July 14, 2026.

How often will SRXH report progress to NYSE American during the Plan Period?

The company will provide quarterly updates to NYSE American on progress toward the plan.

Does NYSE acceptance of the plan guarantee long‑term compliance for SRXH?

NYSE acceptance continues the listing under an extension; final compliance depends on meeting the plan's goals by the July 14, 2026 deadline.